StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)

Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the medical technology company’s stock.

BIOLASE Stock Performance

Shares of BIOL opened at $0.01 on Wednesday. BIOLASE has a fifty-two week low of $0.02 and a fifty-two week high of $1.94. The company has a market capitalization of $325,718.25, a price-to-earnings ratio of 0.00 and a beta of 0.67. The firm has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.02.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.